EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $11,049,000 | -57.1% | 513,410 | -55.8% | 0.08% | -61.9% |
| Q1 2018 | $25,753,000 | -43.8% | 1,162,644 | -22.8% | 0.22% | -45.1% |
| Q4 2017 | $45,798,000 | -9.2% | 1,506,499 | -27.6% | 0.40% | -2.9% |
| Q3 2017 | $50,447,000 | -1.6% | 2,082,012 | 0.0% | 0.41% | -8.7% |
| Q2 2017 | $51,280,000 | -9.1% | 2,082,012 | -20.0% | 0.45% | -3.0% |
| Q1 2017 | $56,419,000 | +26.0% | 2,603,569 | -13.3% | 0.46% | +5.2% |
| Q4 2016 | $44,783,000 | -29.0% | 3,003,569 | -39.1% | 0.44% | -23.3% |
| Q3 2016 | $63,048,000 | +212.9% | 4,929,494 | +91.1% | 0.57% | +171.1% |
| Q2 2016 | $20,150,000 | +95.3% | 2,580,000 | 0.0% | 0.21% | +93.6% |
| Q1 2016 | $10,320,000 | – | 2,580,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |